Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by educational grants from AbbVie, Inc., Actavis Laboratories, Inc., Prometheus Laboratories, Inc., and Shire.
Target Audience: The intended audience for this activity is gastroenterologists, internal medicine physicians and other healthcare professionals involved in the treatment of patients with inflammatory bowel disease (IBD).
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to assess the most appropriate medical and surgical treatment options for induction and maintenance of remission in mild-to-moderate and moderate-to-severe inflammatory bowel disease.
Faculty:
Stephen B. Hanauer, MD
Clifford Joseph Barborka Professor of Medicine
Northwestern University Feinberg School of Medicine
Medical Director, Digestive Health Center
Chicago, IL
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material was originally approved for 2 years from the date of original release, July 8, 2015, to July 7, 2017. It has since been recertified for an additional year and will now expire on July 7, 2018.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME Content, complete the CME posttest, and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Faculty:
Stephen B. Hanauer, MD
Reviewers:
Gary R. Lichtenstein, MD
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 6/8/2017)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.
Faculty member reports the following relationship(s) which are accurate at the time of original content release (July 8, 2015):
Stephen B. Hanauer, MD
Consulting Fee:AbbVie, Actavis, Amgen, Arena, Astellas, Astra, Baxter, Boehringer-Ingelheim, BMS, Catabasis, Celltrion, Cubist, Ferring, Forest Labs, Genetech, Glenmark, GSK, Hospira, Jansssen, Killy, Luitpold/American Regent, Meda, Novartis, Novo Nordisk, Pfizer, Prometheus, Receptos, Salix, Sanofi, Seattle Genetics, Seres Health, Shire, Takeda, Theradiag, Tigenex, UCB
Speakers Bureau: AbbVie, Janssen, Takeda
Contracted Research: AbbVie, Amgen, Genetech, GSK, Janssen, Lilly, Luitpold/American Regent, Novartis, Novo Nordisk, Pfizer, Prometheus, Receptos, Sanofi, Takeda, UCB
Reviewers reports the following relationship(s):
Gary R. Lichtenstein, MD , FACP, FACG, AGAF
Book Royalty: SLACK, Inc.
Consulting Fee: Abbott Corporation/AbbVie, Actavis, Alaven, Ferring, Hospira, Janssen Orthobiotech, Luitpold/American Regent, Pfizer, Prometheus Laboratories, Inc., Salix Pharmaceuticals, Santarus, Shire Pharmaceuticals, Takeda, UCB Pharma, Warner Chilcott
Contracted Research: Ferring, Janssen Orthobiotech, Prometheus Laboratories, Inc., Salix Pharmaceuticals, Santarus, Shire Pharmaceuticals, UCB Pharma, Warner Chilcott
Funding to the University of Pennsylvania for IBD Fellow Education: Janssen Orthobiotech, Warner Chilcott
Editor (Honorarium): Clinical Advances in Gastroenterology, Gastroenterology and Hepatology, Springer Science and Business Media
Authorship (Honorarium): McMahon Publishing, UpToDate
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 4/20/2017)
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement (for use in Enduring Materials):
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com.